Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors

Clinical trial NCT02415153 · COMPLETED

Trial details

NCT number: NCT02415153
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neurofibromatosis Type 1 Recurrent Childhood Brain Stem Glioma Recurrent Childhood Visual Pathway Glioma Recurrent Primary Central Nervous System Neoplasm Refractory Primary Central Nervous System Neoplasm

Start date: 2015-07-14
Primary completion: 2019-07-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.